Biobankonomics

Developing a sustainable business model approach for the formation of a human tissue Biobank

Jimmie Vaught, Joyce Rogers, Todd Carolin, Carolyn Compton

Research output: Contribution to journalArticle

Abstract

The preservation of high-quality biospecimens and associated data for research purposes is being performed in variety of academic, government, and industrial settings. Often these are multimillion dollar operations, yet despite these sizable investments, the economics of biobanking initiatives is not well understood. Fundamental business principles must be applied to the development and operation of such resources to ensure their long-term sustainability and maximize their impact. The true costs of developing and maintaining operations, which may have a variety of funding sources, must be better understood. Among the issues that must be considered when building a biobank economic model are: understanding the market need for the particular type of biobank under consideration and understanding and efficiently managing the biobank's "value chain," which includes costs for case collection, tissue processing, storage management, sample distribution, and infrastructure and administration. By using these value chain factors, a Total Life Cycle Cost of Ownership (TLCO) model may be developed to estimate all costs arising from owning, operating, and maintaining a large centralized biobank. The TLCO approach allows for a better delineation of a biobank's variable and fixed costs, data that will be needed to implement any cost recovery program. This article represents an overview of the efforts made recently by the National Cancer Institute's Office of Biorepositories and Biospecimen Research as part of its effort to develop an appropriate cost model and cost recovery program for the cancer HUman Biobank (caHUB) initiative. All of these economic factors are discussed in terms of maximizing caHUB's potential for long-term sustainability but have broad applicability to the wide range of biobanking initiatives that currently exist. Published by Oxford University Press 2011.

Original languageEnglish (US)
Pages (from-to)24-31
Number of pages8
JournalJournal of the National Cancer Institute. Monographs
Issue number42
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Costs and Cost Analysis
Ownership
Life Cycle Stages
Economics
Economic Models
National Cancer Institute (U.S.)
Research
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Biobankonomics : Developing a sustainable business model approach for the formation of a human tissue Biobank. / Vaught, Jimmie; Rogers, Joyce; Carolin, Todd; Compton, Carolyn.

In: Journal of the National Cancer Institute. Monographs, No. 42, 2011, p. 24-31.

Research output: Contribution to journalArticle

@article{9e0aba5f2c37483a869e0b9813944425,
title = "Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue Biobank",
abstract = "The preservation of high-quality biospecimens and associated data for research purposes is being performed in variety of academic, government, and industrial settings. Often these are multimillion dollar operations, yet despite these sizable investments, the economics of biobanking initiatives is not well understood. Fundamental business principles must be applied to the development and operation of such resources to ensure their long-term sustainability and maximize their impact. The true costs of developing and maintaining operations, which may have a variety of funding sources, must be better understood. Among the issues that must be considered when building a biobank economic model are: understanding the market need for the particular type of biobank under consideration and understanding and efficiently managing the biobank's {"}value chain,{"} which includes costs for case collection, tissue processing, storage management, sample distribution, and infrastructure and administration. By using these value chain factors, a Total Life Cycle Cost of Ownership (TLCO) model may be developed to estimate all costs arising from owning, operating, and maintaining a large centralized biobank. The TLCO approach allows for a better delineation of a biobank's variable and fixed costs, data that will be needed to implement any cost recovery program. This article represents an overview of the efforts made recently by the National Cancer Institute's Office of Biorepositories and Biospecimen Research as part of its effort to develop an appropriate cost model and cost recovery program for the cancer HUman Biobank (caHUB) initiative. All of these economic factors are discussed in terms of maximizing caHUB's potential for long-term sustainability but have broad applicability to the wide range of biobanking initiatives that currently exist. Published by Oxford University Press 2011.",
author = "Jimmie Vaught and Joyce Rogers and Todd Carolin and Carolyn Compton",
year = "2011",
doi = "10.1093/jncimonographs/lgr009",
language = "English (US)",
pages = "24--31",
journal = "NCI Monographs",
issn = "1052-6773",
publisher = "Oxford University Press",
number = "42",

}

TY - JOUR

T1 - Biobankonomics

T2 - Developing a sustainable business model approach for the formation of a human tissue Biobank

AU - Vaught, Jimmie

AU - Rogers, Joyce

AU - Carolin, Todd

AU - Compton, Carolyn

PY - 2011

Y1 - 2011

N2 - The preservation of high-quality biospecimens and associated data for research purposes is being performed in variety of academic, government, and industrial settings. Often these are multimillion dollar operations, yet despite these sizable investments, the economics of biobanking initiatives is not well understood. Fundamental business principles must be applied to the development and operation of such resources to ensure their long-term sustainability and maximize their impact. The true costs of developing and maintaining operations, which may have a variety of funding sources, must be better understood. Among the issues that must be considered when building a biobank economic model are: understanding the market need for the particular type of biobank under consideration and understanding and efficiently managing the biobank's "value chain," which includes costs for case collection, tissue processing, storage management, sample distribution, and infrastructure and administration. By using these value chain factors, a Total Life Cycle Cost of Ownership (TLCO) model may be developed to estimate all costs arising from owning, operating, and maintaining a large centralized biobank. The TLCO approach allows for a better delineation of a biobank's variable and fixed costs, data that will be needed to implement any cost recovery program. This article represents an overview of the efforts made recently by the National Cancer Institute's Office of Biorepositories and Biospecimen Research as part of its effort to develop an appropriate cost model and cost recovery program for the cancer HUman Biobank (caHUB) initiative. All of these economic factors are discussed in terms of maximizing caHUB's potential for long-term sustainability but have broad applicability to the wide range of biobanking initiatives that currently exist. Published by Oxford University Press 2011.

AB - The preservation of high-quality biospecimens and associated data for research purposes is being performed in variety of academic, government, and industrial settings. Often these are multimillion dollar operations, yet despite these sizable investments, the economics of biobanking initiatives is not well understood. Fundamental business principles must be applied to the development and operation of such resources to ensure their long-term sustainability and maximize their impact. The true costs of developing and maintaining operations, which may have a variety of funding sources, must be better understood. Among the issues that must be considered when building a biobank economic model are: understanding the market need for the particular type of biobank under consideration and understanding and efficiently managing the biobank's "value chain," which includes costs for case collection, tissue processing, storage management, sample distribution, and infrastructure and administration. By using these value chain factors, a Total Life Cycle Cost of Ownership (TLCO) model may be developed to estimate all costs arising from owning, operating, and maintaining a large centralized biobank. The TLCO approach allows for a better delineation of a biobank's variable and fixed costs, data that will be needed to implement any cost recovery program. This article represents an overview of the efforts made recently by the National Cancer Institute's Office of Biorepositories and Biospecimen Research as part of its effort to develop an appropriate cost model and cost recovery program for the cancer HUman Biobank (caHUB) initiative. All of these economic factors are discussed in terms of maximizing caHUB's potential for long-term sustainability but have broad applicability to the wide range of biobanking initiatives that currently exist. Published by Oxford University Press 2011.

UR - http://www.scopus.com/inward/record.url?scp=80053402730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053402730&partnerID=8YFLogxK

U2 - 10.1093/jncimonographs/lgr009

DO - 10.1093/jncimonographs/lgr009

M3 - Article

SP - 24

EP - 31

JO - NCI Monographs

JF - NCI Monographs

SN - 1052-6773

IS - 42

ER -